Orexo announces positive data from an in-vivo study of OX390

Join Pharma | Login

	Editorial


	ACT FAST ON COPP ISSUANCE
	Wednesday, May 20, 2026
	Effective from August 15, 2025, the Central Drugs Standard Control Organisation (CDSCO) had mandated that applications for the World Health Organization-Good Manufacturing Practices (WHO-GMP)
	Past Editorial...

TODAY'S NEWS


18:00 [IST]	Orexo announces positive data from an in-vivo study of OX390
17:30 [IST]	CarePay survey shows 6 in 10 patients leave without treatment after consultation amid financing delays
17:25 [IST]	Dr Reddy’s Labs launches oral semaglutide biosimilar ‘Obeda’ tablets in India
17:15 [IST]	Ichnos Glenmark Innovation announces new development candidate, ISB 2301, a first-in-class multispecific immune cells activator targeting solid tumours
17:10 [IST]	Tukaram Mundhe takes over as new Maharashtra FDA Commissioner
17:00 [IST]	US FDA grants priority review status to Bayer’s sevabertinib for first-line treatment for patients with HER2-mutant non-small cell lung cancer

more news >>

TOP NEWS


08:00 [IST]	CDSCO asks SLAs to take strict action against violation of regulations on GLP-1 based weight loss drugs
08:00 [IST]	RGIA’s new Cargo Terminal 2 to accelerate pharma and medical device exports from Hyderabad
08:00 [IST]	Central drug regulator cannot prosecute pharma unit under Chapter IV of D&C Act: Himachal High Court
08:00 [IST]	IPC reports rising ADRs linked to antidepressants as PvPI strengthens drug safety monitoring in India
08:00 [IST]	Pharmac South 2026 to anchor high-level technical seminars and regulatory dialogues in its 11th edition
08:00 [IST]	IDMA recommends NITI Aayog 3-year cut-off period for overcharging cases to reduce number of legal cases

more news >>

YESTERDAY'S NEWS


17:20 [IST]	Apollo HomeCare and Apollo AyurVAID collaborate to strengthen post-discharge transition care
16:45 [IST]	Lupin receives US FDA tentative approval for revefenacin inhalation solution
16:30 [IST]	Strides in Q4 delivers 11.2% in revenue growth at Rs. 1323.5 crore, PAT registers 51% increase at Rs. 129.3 crore
16:15 [IST]	HAB Pharma completes strategic merger with Signature Phytochemicals to lead global pharma innovation
15:50 [IST]	CDSCO, Maharashtra FDA assures medicine availability amid AIOCD nationwide strike on May 20
15:45 [IST]	Parexel launches ParexelAI delivering AI innovation to accelerate clinical development

more news >>

INTERVIEW


Uzbekistan offers one of the most dynamic and strategically positioned pharmaceutical markets in Eurasia: Abdulla Azizov
Abdulla Azizov, Chairman of the Medical and Pharmaceutical Industry Development Agency and the First Deputy Minister of Health of the Republic of Uzbekistan

Past Interviews...

	What's New?

Strides in Q4 delivers 11.2% in revenue growth at Rs. 1323.5 crore, PAT registers 51% increase at Rs. 129.3 crore OneSource in Q4 FY26 revenue up 47% at Rs 428.2 crore with adjusted PAT at Rs 39 crore Dr Reddy’s Q4 revenues down by 11.6% at Rs. 7,516 crore, PAT plummeted to 86.2% at Rs. 220 crore Biocon net profit declines 63.4% in Q4 FY26 Indoco Remedies net loss narrows during Q4, FY26

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers